Antioxidants
Antioxidant nutrients and supplements encompass a broad class of compounds that directly neutralize reactive oxygen species, support the enzymatic antioxidant defense network, or reduce the endogenous rate of oxidative damage to DNA, lipids, and proteins; as a category, dietary antioxidants including vitamins C and E, selenium, glutathione precursors, and polyphenols reduce the oxidative burden across multiple cell types and are most relevant in contexts where oxidative stress is a primary driver of pathology, including hemoglobin disorders, neurodegenerative conditions, cancer predisposition syndromes, and inflammatory diseases.
Key Takeaways
- •Antioxidant nutrients work through two complementary strategies: direct radical scavenging (vitamin C, vitamin E, carotenoids) and indirect upregulation of endogenous antioxidant enzymes (selenium for GPX activity, sulforaphane and curcumin for NRF2-driven enzyme induction); the indirect strategy is generally more durable because it amplifies the body's own defenses rather than simply supplementing exogenous scavengers.
- •The clinical benefit of antioxidants is most clearly established in conditions where oxidative stress is a primary mechanistic driver, including sickle cell disease (RBC sickling and hemolysis generate oxidative damage), G6PD deficiency (impaired NADPH production leaves cells vulnerable to oxidative hemolysis), and DNA repair deficiency syndromes where endogenous ROS damage accumulates.
- •TERC and other telomere maintenance genes are particularly vulnerable to oxidative damage because the G-rich repeats of telomeric DNA are preferentially oxidized by hydroxyl radicals; dietary antioxidants reduce this preferential telomere oxidation and are associated with longer leukocyte telomere length in population studies.
- •In hemoglobin disorders including sickle cell disease (HBB variants) and beta-thalassemia, chronic hemolysis generates a sustained cycle of oxidative stress from free heme and iron release; antioxidant supplementation reduces biomarkers of oxidative damage in these conditions and may reduce the frequency of vaso-occlusive crises.
- •The clinical evidence for antioxidants as cancer prevention agents is more complex than the mechanistic rationale predicts; high-dose antioxidant supplementation (particularly high-dose vitamin E and beta-carotene) has failed in large trials and in some cases increased cancer risk, while food-derived antioxidant polyphenols and dietary patterns rich in plant antioxidants consistently associate with reduced cancer risk.
- •Reactive oxygen species produced as byproducts of monoamine oxidase A (MAOA) activity include hydrogen peroxide, which can directly damage dopaminergic neurons; antioxidants capable of penetrating the blood-brain barrier, including N-acetylcysteine and alpha-lipoic acid, are most relevant for neutralizing this neuronal oxidative burden.
- •In amyotrophic lateral sclerosis and FUS/TDP-43 proteinopathies, oxidative stress triggers the translocation of RNA-binding proteins including FUS into cytoplasmic stress granules, initiating the mislocalization and aggregation cascade; antioxidants that reduce the oxidative trigger may delay stress granule formation and protein mislocalization.
Basic Information
- Name
- Antioxidants
- Also Known As
- reactive oxygen species scavengersfree radical scavengersredox nutrientsantioxidant vitaminsdietary antioxidants
- Category
- Antioxidant nutrient class / redox defense support
- Bioavailability
- Varies substantially by compound class. Water-soluble antioxidants (vitamin C, glutathione) are absorbed via intestinal transporters with saturable kinetics; above 1,000 mg per day, vitamin C absorption efficiency declines significantly. Fat-soluble antioxidants (vitamin E tocopherols, carotenoids, CoQ10) require dietary fat for micellar absorption and have highly variable bioavailability influenced by genetic variants in lipid transport genes. Polyphenol antioxidants (quercetin, resveratrol, curcumin) have generally poor oral bioavailability but gut bacterial conversion to active metabolites extends their biological half-lives. Food matrix effects substantially influence antioxidant bioavailability from dietary sources.
- Half-Life
- Highly variable by compound. Vitamin C: plasma half-life of 10 to 20 days at physiological levels but much shorter at pharmacological doses. Vitamin E: tissue half-life of weeks to months due to storage in adipose tissue and cell membranes. Glutathione: plasma half-life of minutes to hours; intracellular glutathione is continuously recycled by glutathione reductase. Polyphenol metabolites: hours to days depending on enterohepatic recirculation. CoQ10: plasma half-life of approximately 33 hours.
Primary Mechanisms
Direct hydrogen atom or electron donation to neutralize free radicals (vitamin C, vitamin E, carotenoids, polyphenols)
Glutathione precursor provision supporting GPX-mediated hydroperoxide reduction (NAC, cysteine)
Selenium incorporation into selenocysteine residues of GPX enzymes, supporting their catalytic activity
Metal chelation preventing Fenton reaction generation of hydroxyl radicals (EDTA, quercetin, IP6)
NRF2 pathway activation inducing endogenous antioxidant enzyme biosynthesis (polyphenols, isothiocyanates)
Mitochondrial superoxide quenching (MitoQ, idebenone, mitochondria-targeted antioxidants)
Quick Safety Summary
Highly compound-specific. Vitamin C: up to 2,000 mg per day generally tolerated; bowel tolerance limits individual maximum. Vitamin E: 100 to 400 IU per day is standard; doses above 400 IU per day associated with increased all-cause mortality in some meta-analyses. Selenium: 55 to 200 mcg per day; above 400 mcg per day risks selenosis. N-acetylcysteine: 600 to 1,800 mg per day in clinical trials. Alpha-lipoic acid: 300 to 600 mg per day in most trials.
Hemochromatosis or iron overload: high-dose vitamin C dramatically increases non-heme iron absorption and can precipitate iron overload crises in HFE carriers and other iron overload conditions; use with caution or avoid at mealtimes, Active chemotherapy with pro-oxidant mechanism of action (doxorubicin, bleomycin, radiation): antioxidants may theoretically blunt the cytotoxic efficacy of treatments that rely on ROS generation; avoid high-dose antioxidant supplementation during these treatments without oncology guidance, Selenium supplementation in selenium-replete populations: randomized trials show that selenium supplementation increases type 2 diabetes risk in people with high baseline selenium; do not supplement without confirming selenium insufficiency
Overview
Antioxidants as a supplement category encompass a diverse set of compounds united by their ability to reduce the net accumulation of reactive oxygen species (ROS) and prevent the oxidative modification of biological macromolecules. The category includes water-soluble electron donors (vitamin C, glutathione), lipid-soluble radical-chain terminators (alpha-tocopherol, carotenoids), selenium-dependent enzyme cofactors (supporting GPX1, GPX4, and TXNRD1), and polyphenolic compounds that activate endogenous antioxidant gene expression through NRF2 and other transcription factors. What unifies these compounds is not a single mechanism but a shared physiological goal: reducing the oxidative modification of DNA (which causes mutagenic 8-oxoguanine and strand breaks), lipids (which causes lipid peroxidation cascades and membrane dysfunction), and proteins (which causes carbonylation, disulfide crosslinking, and aggregation). The clinical relevance of antioxidant supplementation is greatest when oxidative stress is a primary mechanistic driver of pathology rather than a secondary bystander, and this contextual specificity explains the divergence between the compelling mechanistic rationale and the mixed results of large-scale antioxidant supplementation trials.
The distinction between direct antioxidants and indirect antioxidant inducers is critical for understanding the clinical pharmacology of this category. Direct antioxidants (vitamin C, vitamin E, glutathione) donate electrons or hydrogen atoms to neutralize free radicals in a stoichiometric fashion: one molecule of antioxidant neutralizes one radical species. This is effective in acute oxidative stress contexts but is limited by the finite supply of the supplemented antioxidant. Indirect antioxidants (sulforaphane, curcumin, resveratrol) activate NRF2 and other transcription factors to upregulate the biosynthesis of endogenous antioxidant enzymes including glutathione peroxidases, thioredoxin reductases, and superoxide dismutases. Because these enzymes are catalytic, a single induced enzyme molecule can neutralize thousands of radical molecules, and the effect persists for days after the inducer is cleared. The most physiologically complete antioxidant strategy combines both approaches: direct antioxidants for acute protection and NRF2 inducers for sustained enzymatic defense capacity.
The relationship between antioxidants and DNA repair is particularly important in the context of genome maintenance genes. For genes involved in DNA repair (ERCC1, MSH2, PALB2, XRCC1, ATM), oxidative stress represents a primary source of the DNA lesions that these repair systems must manage. 8-oxoguanine, the most abundant oxidative base modification, is mutagenic if not repaired and is generated at an estimated rate of thousands of lesions per cell per day under normal conditions. This rate increases substantially under conditions of chronic inflammation, mitochondrial dysfunction, or environmental oxidant exposure. By reducing the rate of 8-oxoguanine formation, dietary antioxidants reduce the workload on the OGG1/MUTYH base excision repair pathway and on downstream mismatch repair and nucleotide excision repair systems. This supportive relationship between antioxidant nutrients and DNA repair genes is bidirectional: individuals with reduced-function DNA repair gene variants benefit most from reducing the oxidative damage burden, while individuals with high-efficiency repair may benefit less.
Telomere biology provides one of the most compelling translational links between antioxidant supplementation and aging outcomes. Telomeric DNA consists of TTAGGG repeats that are disproportionately targeted by hydroxyl radicals because guanine has the lowest oxidation potential of the four DNA bases and the G-rich telomeric sequence creates locally concentrated guanine targets. Oxidative telomere damage is repaired less efficiently than damage in coding regions because telomeres lack conventional DNA repair templates and must rely on specialized mechanisms. The consequence is that each cycle of oxidative stress produces a small net shortening of telomeres, and cumulative oxidative exposure over decades correlates with accelerated telomere attrition. Population studies consistently find that markers of oxidative stress inversely correlate with leukocyte telomere length, and individuals with higher dietary antioxidant intake have longer telomeres after controlling for other variables. This provides observational support for the mechanistic prediction that antioxidant nutrients protect telomere integrity through the TERC-dependent maintenance pathway.
Gene Interactions
Key Gene Targets
APOL1
APOL1 high-risk variants cause mitochondrial dysfunction and increased reactive oxygen species production in kidney podocytes; antioxidant nutrients are used to combat the elevated ROS generated during APOL1-mediated mitochondrial stress, potentially reducing the oxidative component of podocyte injury that drives the progression to kidney disease in APOL1 variant carriers.
FUS
Oxidative stress is a primary trigger for the translocation of FUS (fused in sarcoma) from the nucleus into cytoplasmic stress granules, initiating the mislocalization and pathological aggregation cascade associated with ALS and frontotemporal dementia; antioxidants capable of reducing cytoplasmic oxidative stress may delay or reduce the frequency of FUS stress granule formation.
HBB
In sickle cell disease, HBB S/S homozygosity causes chronic hemolysis that releases free heme and iron into the bloodstream, generating a sustained cycle of Fenton reaction-driven hydroxyl radical production; antioxidant supplementation is used to reduce the oxidative stress biomarkers (F2-isoprostanes, plasma protein carbonyls) caused by chronic hemolysis and RBC sickling.
SERPINA1
The methionine 358 residue in the active site of alpha-1-antitrypsin (A1AT, encoded by SERPINA1) is oxidized by cigarette smoke oxidants, converting the trypsin inhibitor to a non-functional species; antioxidants may help prevent this oxidative inactivation of A1AT, particularly in the lung lining fluid where cigarette smoke exposure is highest.
TERC
Reactive oxygen species preferentially damage the G-rich TTAGGG telomeric DNA repeats because guanine has the lowest oxidation potential of the four DNA bases; antioxidants reduce the rate of 8-oxoguanine formation in telomeres, preserving telomere integrity and reducing the telomere shortening that would otherwise occur with each oxidative episode, with population studies confirming the correlation between antioxidant intake and leukocyte telomere length.
Safety & Dosing
Contraindications
Hemochromatosis or iron overload: high-dose vitamin C dramatically increases non-heme iron absorption and can precipitate iron overload crises in HFE carriers and other iron overload conditions; use with caution or avoid at mealtimes
Active chemotherapy with pro-oxidant mechanism of action (doxorubicin, bleomycin, radiation): antioxidants may theoretically blunt the cytotoxic efficacy of treatments that rely on ROS generation; avoid high-dose antioxidant supplementation during these treatments without oncology guidance
Selenium supplementation in selenium-replete populations: randomized trials show that selenium supplementation increases type 2 diabetes risk in people with high baseline selenium; do not supplement without confirming selenium insufficiency
Drug Interactions
Warfarin and other anticoagulants: high-dose vitamin E may potentiate warfarin anticoagulant effect; monitor INR if supplementing above 100 IU per day
Statin medications: some data suggest antioxidants may blunt the HDL-raising effects of niacin-statin combinations; the clinical significance is debated
PARP inhibitor chemotherapy: antioxidants that reduce DNA oxidative damage may reduce the strand break load that activates PARP, potentially altering PARP inhibitor pharmacodynamics
Copper metabolism: high-dose zinc (an antioxidant cofactor) depletes copper by inducing metallothionein, which preferentially binds copper; long-term high-dose zinc supplementation requires copper co-supplementation
Common Side Effects
GI discomfort (nausea, diarrhea) is common at higher doses of most water-soluble antioxidants, particularly vitamin C above 1,000 mg and NAC above 1,800 mg per day
Oxidative pro-drug effects at very high doses: paradoxically, very high doses of some antioxidants (vitamin C, vitamin E) can become pro-oxidant under certain conditions; this is relevant primarily at pharmacological rather than dietary doses
Studied Doses
Highly compound-specific. Vitamin C: up to 2,000 mg per day generally tolerated; bowel tolerance limits individual maximum. Vitamin E: 100 to 400 IU per day is standard; doses above 400 IU per day associated with increased all-cause mortality in some meta-analyses. Selenium: 55 to 200 mcg per day; above 400 mcg per day risks selenosis. N-acetylcysteine: 600 to 1,800 mg per day in clinical trials. Alpha-lipoic acid: 300 to 600 mg per day in most trials.
Mechanism of Action
The mechanism of action varies fundamentally by antioxidant class. Vitamin C (ascorbate) is the primary water-soluble antioxidant in human plasma, donating electrons to quench hydroxyl radicals, superoxide, and reactive nitrogen species. After donating one electron, ascorbate becomes the ascorbyl radical, which is relatively stable and can be recycled back to ascorbate by NADH or NADPH-dependent reductases. Vitamin C also recycles oxidized vitamin E (tocopheryl radical) at the membrane-aqueous interface, effectively extending the antioxidant capacity of both vitamins. Vitamin E (alpha-tocopherol) is the primary lipid-soluble antioxidant in cell membranes, interrupting lipid peroxidation chain reactions by donating a hydrogen atom to lipid peroxyl radicals and converting them to less reactive species before they can propagate the oxidative chain. Glutathione (GSH) is the most abundant intracellular antioxidant, reduced to GSSG after neutralizing hydroperoxides via glutathione peroxidase (GPX) enzymes, and recycled back to GSH by glutathione reductase using NADPH from the pentose phosphate pathway.
Selenium is a critical antioxidant cofactor rather than a direct antioxidant: it is incorporated as selenocysteine into the active sites of the GPX family of enzymes (GPX1-GPX8), the thioredoxin reductase family (TXNRD1-3), and selenoprotein P. Without adequate selenium, these selenoenzymes cannot be synthesized, reducing the cellular capacity for glutathione-dependent and thioredoxin-dependent hydroperoxide reduction. The relationship between selenium status and antioxidant capacity therefore follows a threshold model rather than a dose-response model: below the threshold for selenoprotein saturation, selenium supplementation improves antioxidant capacity, but above this threshold, additional selenium provides no antioxidant benefit and may increase metabolic toxicity.
Clinical Evidence
The most clinically meaningful evidence for antioxidant supplementation comes from contexts where oxidative stress is specifically elevated above the endogenous defense capacity. In sickle cell disease (HBB S/S), chronic intravascular hemolysis generates continuous free heme and iron release that drives Fenton chemistry, overwhelming the endogenous antioxidant system. Clinical trials with N-acetylcysteine and antioxidant combinations in sickle cell patients have shown reductions in F2-isoprostane levels, reduced neutrophil activation, and in some studies reduced crisis frequency. In alpha-1 antitrypsin deficiency (SERPINA1), the methionine 358 in the A1AT active site is oxidized by cigarette smoke-derived oxidants, inactivating the protease inhibitor and potentiating the neutrophil elastase-driven lung destruction; antioxidant support reduces A1AT inactivation in cell models. Population-level evidence consistently shows that higher dietary antioxidant intake (assessed by food frequency questionnaire) associates with longer telomere length, lower all-cause mortality, and reduced cancer risk, in contrast to the null results from isolated supplementation trials, reflecting the synergistic and matrix-dependent nature of food-derived antioxidant activity.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Comprehensive Cochrane meta-analysis of 78 randomized trials including 296,707 participants showing that supplementation with beta-carotene, vitamin A, and vitamin E increased all-cause mortality, while vitamin C and selenium did not significantly affect mortality; established the evidence base for caution with high-dose isolated antioxidant supplementation and shifted emphasis toward dietary antioxidant sources.
Large randomized trial in 35,533 men showing that vitamin E supplementation (400 IU per day) significantly increased prostate cancer risk by 17 percent after 5.5 years of follow-up, despite the strong mechanistic rationale for antioxidant cancer prevention; this landmark negative trial fundamentally altered the clinical approach to antioxidant supplementation.
Mechanistic review establishing that oxidative stress preferentially damages telomeric DNA due to the low oxidation potential of guanine, that telomere single-strand breaks are repaired less efficiently than elsewhere in the genome, and that antioxidant treatment reduces the rate of oxidative telomere shortening in cell culture models, providing the mechanistic foundation for the antioxidant-telomere length relationship observed in population studies.
Review of clinical and mechanistic evidence showing that oxidative stress is a central driver of vaso-occlusive pathology in sickle cell disease and that antioxidant interventions including NAC, vitamin C, and arginine reduce oxidative biomarkers and may reduce crisis frequency, establishing the framework for antioxidant supplementation in HBB-variant disease.
Systematic review of 183 prospective studies finding that higher dietary antioxidant intake from food sources was consistently associated with reduced all-cause mortality and cancer risk, in contrast to the null or negative results from isolated antioxidant supplement trials; provides the evidence base for prioritizing food-derived antioxidant patterns over high-dose supplementation.